Donor leukocyte infusion as salvage therapy in an adult with relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation

Journal of the Formosan Medical Association

Volumn 97, Issue 1, 1998, Pages 55-58

  Chang, Chao Sung ^a   Lin, Sheng Fung ^a   Liu, Ta Chih ^a   Huang, Shu Mu ^a   Chen, Tyen Po ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Allogeneic bone marrow; Donor leukocyte infusion; Leukemia; Transplantation

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; FEMALE; HUMAN; INFUSION; LEUKOCYTE; LEUKOCYTE TRANSFUSION; RELAPSE; SALVAGE THERAPY; TREATMENT FAILURE;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKOCYTE TRANSFUSION; RECURRENCE; SALVAGE THERAPY;

EID: 0031887050     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Goldman JM, Gale RP, Horowitz MM, et al: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T cell depletion. Ann Intern Med 1988; 108:806-14.
2. International Bone Marrow Transplant Registry: Transplant or chemotherapy in acute myelogenous leukemia. Lancet 1989;i:1119-22.
3. Barrett AJ, Horowitz MM, Gale RP, et al: Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989;74:862-71.
4. Mortimer J, Blinder MA, Schulman S, et al: Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol 1989;7:50-7.
5. Barrett AJ, Locatelli F, Treleaven JG, et al: Second transplants for leukemia relapse after bone marrow transplantation: high early mortaliry but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukemia Working Party. Br J Haematol 1991;79:567-74.
6. Arcese W, Goldmann JM, D'Arcangelo E, et al: Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic leukemia working party. European Bone Marrow Transplantation Group. Blood 1993;82:3211-9.
7. Kolb HJ, MittermuellerJ, Clemm C, et al: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990;76:2462-5.
8. Russell LA, Jacobseu N, Heilmann C, et al: Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients. Bone Manow Transplant 1996;18.411-4.
9. Kolb HJ, Schattenberg A, Goldman JM, et al: Graftversus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995;86:2041-50.
10. Collins RH, Shpilberg O Jr, Drobyski WR, et al: Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997;15:433-44.
11. Ferster A, Bujan W, Mouraux T, et al: Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant 1994;14:331-2.
12. Sica S, Di Mario A, Salutari P, et al: Chemotherapy and recombinant human granulocyte colony-stimulating factor primed donor leukocyte infusion for treatment of relapse after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;16:483-5.
13. Bunjes D, Theobald M, Hertenstein B, et al: Successful therapy with donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1995;15:713-9.
14. Jiang YG, Cullis JO, Kanfer EJ, et al: T cell and NK cell mediated graft-versus leukemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1993;11:133-8.
15. Mackinnon S, Papadopoulos EB, Carabasi MH, et al: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of GVL responses from GVHD. Blood 1995;86: 1261-8.